GlassScriptPhysician profile
Veronica Huber
NPI 1841753563
$1,248.84
in general payments reported to CMS, 2019-2025
17 companies · $405 in 2025
The $405 reported for 2025 was more than what 82% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2023: $221 · 2024: $292 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.24 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $324.94 | 2023-2025 | Veozah |
| Abbvie INC. | $212.01 | 2021-2023 | |
| Organon LLC | $123.37 | 2023-2025 | Nexplanon |
| Sage Therapeutics, LLC | $101.20 | 2021-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $94.37 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $71.65 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $52.44 | 2021-2025 | |
| Myovant Sciences INC. | $43.99 | 2021 | |
| Sumitomo Pharma America, INC. | $43.27 | 2025 | Myfembree |
| Vertex Pharmaceuticals Incorporated | $38.59 | 2025 | |
| Mayne Pharma Commercial LLC | $33.95 | 2025 | |
| Supernus Pharmaceuticals, INC. | $27.82 | 2025 | Qelbree |
| Millicent US INC | $20.69 | 2025 | Intrarosa |
| Exact Sciences Corporation | $20.00 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $14.87 | 2025 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $14.05 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.